BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 31676330)

  • 1. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
    Carmicheal J; Patel A; Dalal V; Atri P; Dhaliwal AS; Wittel UA; Malafa MP; Talmon G; Swanson BJ; Singh S; Jain M; Kaur S; Batra SK
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188318. PubMed ID: 31676330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cystic pancreatic tumors: diagnostics and new biomarkers].
    Berger AW; Seufferlein T; Kleger A
    Chirurg; 2017 Nov; 88(11):905-912. PubMed ID: 28831506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action.
    Dalal V; Carmicheal J; Dhaliwal A; Jain M; Kaur S; Batra SK
    Cancer Lett; 2020 Jan; 469():228-237. PubMed ID: 31629933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
    Henry JC; Bassi C; Giovinazzo F; Bloomston M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Detection of Pancreatic Cancer: Opportunities and Challenges.
    Singhi AD; Koay EJ; Chari ST; Maitra A
    Gastroenterology; 2019 May; 156(7):2024-2040. PubMed ID: 30721664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.
    Vila-Navarro E; Vila-Casadesús M; Moreira L; Duran-Sanchon S; Sinha R; Ginés À; Fernández-Esparrach G; Miquel R; Cuatrecasas M; Castells A; Lozano JJ; Gironella M
    Ann Surg; 2017 Jun; 265(6):1226-1234. PubMed ID: 27232245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign, premalignant and malignant pancreatic cystic lesions: the pathology landscape.
    Demetter P; Verset L
    Acta Gastroenterol Belg; 2017; 80(2):293-298. PubMed ID: 29560696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic diagnosis of pancreatic cysts.
    Blaszczak AM; Krishna SG
    Curr Opin Gastroenterol; 2019 Sep; 35(5):448-454. PubMed ID: 31219827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strategy in intraductal papillary mucinous neoplasm of the pancreas].
    Navarro Colás S; Vaquero Raya EC
    Gastroenterol Hepatol; 2012 Nov; 35(9):652-9. PubMed ID: 22832084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
    Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
    Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management.
    El Gammal AT; Izbicki JR
    Surg Clin North Am; 2018 Feb; 98(1):141-155. PubMed ID: 29191271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer.
    Ohno E; Hirooka Y; Kawashima H; Ishikawa T; Kanamori A; Ishikawa H; Sasaki Y; Nonogaki K; Hara K; Hashimoto S; Matsubara H; Hirai T; Sumi H; Sugimoto H; Goto H;
    J Gastroenterol Hepatol; 2018 Jan; 33(1):320-328. PubMed ID: 28872701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the diagnostic evaluation of pancreatic cystic lesions.
    Ardeshna DR; Cao T; Rodgers B; Onongaya C; Jones D; Chen W; Koay EJ; Krishna SG
    World J Gastroenterol; 2022 Feb; 28(6):624-634. PubMed ID: 35317424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.
    Tada M; Kawabe T; Arizumi M; Togawa O; Matsubara S; Yamamoto N; Nakai Y; Sasahira N; Hirano K; Tsujino T; Tateishi K; Isayama H; Toda N; Yoshida H; Omata M
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1265-70. PubMed ID: 16979953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
    Distler M; Welsch T; Aust D; Weitz J; Grützmann R
    Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer.
    Konings IC; Harinck F; Poley JW; Aalfs CM; van Rens A; Krak NC; Wagner A; Nio CY; Sijmons RH; van Dullemen HM; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ;
    Pancreas; 2017 Jan; 46(1):28-34. PubMed ID: 27846136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
    Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
    Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.